Press Release: Delve : Delve Bio Announces Launch of its Groundbreaking Genomic Infectious Disease Test, Delve Detect
Delve Detect provides comprehensive metagenomic next generation sequencing (mNGS) for central nervous system infections, with rapid turnaround time and robust clinical support BOSTON--(BUSINESS...
Read full article »
Delve is a California-based biotechnology company that provides metagenomic next-generation sequencing solutions for laboratories and clinicians.
Read more